DEI

Tufts CSDD study finds that acts of microaggression negatively impact psychological safety and performance.

Amidst difficulty in attracting underrepresented populations, industry is searching for ways to include more diverse datasets.

Expanded offerings will increase Black representation in clinical trials, ensuring that new medicines are safe and effective for people of color.

Survey examines trial enrollment motivation among diverse populations.

Advancing responsible AI innovation to help resolve patient disparities.

Outlining new approaches and resources to help ignite progress in this area.

Panel discussion at SCOPE highlights strategies to increase diversity in clinical trials.

Regulatory compliance, collaboration, and effective use of technology among ways CROs can overcome challenges.

Measuring different dimensions of diversity beforehand can lead to more thoughtful planning and execution.